|
BAZ1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31030000003219E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00520000004367E-06 |
| Normal-vs-Stage2 |
5.523200E-01 |
| Normal-vs-Stage3 |
1.257350E-03 |
| Normal-vs-Stage4 |
1.043730E-04 |
| Stage1-vs-Stage2 |
1.041280E-03 |
| Stage1-vs-Stage3 |
3.742800E-01 |
| Stage1-vs-Stage4 |
1.413380E-01 |
| Stage2-vs-Stage3 |
1.178420E-02 |
| Stage2-vs-Stage4 |
5.800700E-04 |
| Stage3-vs-Stage4 |
6.798400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46189999997259E-06 |
| Normal-vs-AfricanAmerican |
4.256600E-03 |
| Normal-vs-Asian |
1.704960E-03 |
| Caucasian-vs-AfricanAmerican |
9.054200E-01 |
| Caucasian-vs-Asian |
8.717400E-01 |
| AfricanAmerican-vs-Asian |
8.388400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.96430000000336E-05 |
| Normal-vs-Female |
3.67639999999669E-05 |
| Male-vs-Female |
2.860000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.13529999956619E-07 |
| Normal-vs-Age(41-60Yrs) |
4.422600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.263000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.757600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.664550E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.487800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.302200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.146800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.981800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.967800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.503800E-01 |
| Classical-VS-Follicular |
3.18330000004252E-06 |
| Classical-VS-Other |
2.781000E-01 |
| Classical-VS-Normal |
4.390499996898E-08 |
| Tall-VS-Follicular |
1.862130E-02 |
| Tall-VS-Other |
3.883800E-01 |
| Tall-VS-Normal |
1.483840E-03 |
| Follicular-VS-Other |
6.601400E-01 |
| Follicular-VS-Normal |
3.495000E-01 |
| Other-VS-Normal |
3.281800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.451700E-02 |
| Normal-vs-N1 |
1.70089999995682E-06 |
| N0-vs-N1 |
1.362320E-04 |
|
|
